Send Your Enquiry
Dr. Nil Molinas Mandel
4.2 (107 Ratings)
Medical Oncologist
American Hospital, Istanbul · Istanbul
29+ years of experience
About Dr. Bulent Karagoz
- Dr. Bulent Karagoz is a renowned Medical Oncologist with experience of over 20 years.
- His area of specialization covers Tumour Biology, Tumour Immunology, Immunotherapy of Cancer, and Targeted Therapies, etc.
- He is a member of the Turkish Medical Oncology Association.
- He is actively involved in research and has numerous publications to his credit in National and International journals.
- He completed Graduation from Gülhane Military Medical Academy, Faculty of Medicine, Istanbul in 1992. Thereafter, he did Postgraduation in Internal Medicine from GATA Haydarpaşa Training Hospital, in 1999. Then he did Medical Oncology Minor Training from GATA Haydarpaşa Training Hospital, in 2006. He also did the following courses: tumor Biology Course, Association of Medical Oncology, 2003, Applied Flow Cytometry Training, Istanbul University (DETAE), 2004, Basic Epidemiology (Research Methods and Analysis Techniques in Health) Course, GATA Command, 2005 and Ethical Approach in Clinical Research Course, Ministry of Health General Directorate of Pharmaceuticals and Pharmacy, 2009 and 2017 (twice)
Location
Graduation, Gülhane Military Medical Academy, Faculty of Medicine(1992)- Post Graduation, Internal Medicine, GATA Haydarpaşa Training Hospital, Internal Medicine Specialist Training(1999)
- Post Graduation, Medical Oncology, GATA Haydarpaşa Training Hospital, Medical Oncology Minor Training(2006)
Papers Published
- Associated with research and has several publications to his credit in National and International journals. These are: Kandemir, EG, A. Mayadagli, B. Karagoz, O. Bilgi, O. Turken and M. Yaylaci, “Prognostic Significance of Thrombocytosis in Node-negative Colon Cancer, Int J Int Med Res, 33 (2), 228-235 (2005).
+ Read More- Show Less
- Karagöz, B., S. Süleymanoğlu, G. Uzun, O. Bilgi, S. Aydınöz, A. Haholu, O. Türken, Y. Importance and EG Kandemir, “Hyperbaric Oxygen Therapy Does Not Potentiate Doxorubicin-induced Cardio toxicity in Rats, Basic Clin Pharmacol Toxicol, 102 (3), 287-292 (2008).
- Knowledge, O., B. Karagöz, O. Turken, EG Kandemir, A. Ozturk, M. Gumus and M. Yaylaci, “Peripheral Blood Gamma-Delta T Cells in Advanced Stage Cancer Patients,” Adv Ther, 25 (3) ), 218-224 (2008).
- Erikci, AA, A. Ozturk, B. Karagoz, O. Bilgi, O. Turken, C. Top and EG Kandemir, “Results of Combination Therapy with Amifostine, Pentoxifylline, Ciprofloxacin and Dexamethasone in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukaemia, Haematology, 13 (5), 289-292 (2008)
- Aydinoz, S., G. Uzun, H. Cermik, EM Atasoyu, Ş. Yildiz, B. Karagoz and R. Evrenkaya, “Effect of Different Doses of Hyperbaric Oxygen on Cisplatin-Induced Nephro-toxicity,” Ren Fail, 29 (3), 1-7 (2007).
- Erikci, AA, B. Karagoz, A. Ozturk, S. Caglayan, G. Ozisik, i. Kaygusuz and M. Ozata, "The Effect of Subclinical Hypothyroidism on Platelet Parameters," Haematology, 14 (2), 115-117 (2009).
- Karagoz, B., O. Information, M. Gumus, AA Erikci, Ö. Sayan, O. Turken, EG Kandemir, A. Ozturk and M. Yaylaci, “CD8 + CD28- Cells and CD4 + CD25 + Regulatory T cells in The Peripheral Blood of Advanced Stage Lung Cancer Patients,” Med Oncol, 27 (1), 29-33 (2010).
- Erikci, AA, B. Karagoz, M. Ozyurt, A. Ozturk, S. Kilic and O. Bilgi, “HLA-G Expression in B Chronic Lymphocytic Leukaemia: A New Prognostic Marker?” Haematology, 14 (2), 101- 105 (2009)
- Karagöz, B., O. Information, EG Kandemir, Ö. Sayan, AA Erikci, A. Ozgun, B. Yilmaz and A. Ozturk, “Decreased NKG2D Expression on Natural Killer Cells in Gastric Cancer Patients”, UHOD, 19 (1), 42-47 (2009).
- Karagöz, B., O. Bilgi, A. Alacacıoğlu, A. Özgün, Ö Sayan, AA Erikçi and EG Kandemir, “Mean Platelet Volume Increase after Tamoxifen, but not after Anastrazole in Adjuvant Therapy of Breast Cancer,” Med Oncol, 27 (2), 199-202 (2010).
- Karagoz, B., O. Information, EG Kandemir, AA Erikci, Ö. Sayan, Ö. Alpaslan, B. Yilmaz, O. Turken, A. Alacacioglu, A. Ozturk, “CD4 + CRTH2 + Cells in Advanced Stage Non Small Cell Lung Cancer,” Central European Journal of Medicine, 5: 431 (2010)
- Karagöz, B., İ. Sücüllü, Ö. Sayan, O. Bilgi, T. Tuncel, A. İ. Filiz, E. Yucel, A. Ozgun, AA Erikci, A. Alacacioglu and EG Kandemir, “Platelet indices in patients with colorectal cancer”, Central European Journal of Medicine, 5: 365 (2010).
- Özgün, A., B. Karagöz, O. Bilgi, EG Kandemir and O. Türken, “The Prognostic Significance of Co-morbidity and Relation of Co-morbidity with Patients with Non-Small Cell Lung Cancer U, UHOD, 19 (2) ), 63-68 (2009).
- Cetinkaya H, Karagoz B, Information O, Ozgun A, Tuncel T, Emirzeoglu L, Top C, Kandemir EG. Nesfatin-1 in advanced lung cancer patients with weight loss, Regulatory Peptides 2013; 181: 1-3.
- Ozgun A, Karagoz B, Bilgi O, Tuncel T, Baloglu H, Kandemir EG MicroRNA-21 as an Indicator of Aggressive Phenotype in Breast Cancer. Onkologie 2013; 36: 115-118.
- Tuncel, T., B. Karagoz, A. Haholu, A. Ozgun, L. Emirzeoglu, and O. Bilgi and EG Kandemir, “Immuno-regulatory Function of HLA-G in Gastric Cancer, Asian Pac J Cancer Prev. 2013; 14 (12): 7681-4.
- Ozgun A., B. Karagoz, T. Tuncel, L. Emirzeoglu, S. Celik and O. Bilgi, “Clinicopathological features and survival of young Turkish patients with testicular germ cell tumours.” Asian Pac J Cancer Prev. 2013; 14 (11): 6889-92.
- Haholu A., U. Berber, B. Karagoz, T. Tuncel, O. Bilgi and D. Demirel, “There is no association of glutathione S-transferase T1 (GSTT1) and glutathione S-transferase M1 (GSTM1) gene polymorphism with gastric cancers? ” Pol J Pathol, 2013; 64 (4): 247-52.
- Karagoz B., A. Haholu, A. Ozgun, O. Bilgi, T. Tuncel, L. Emirzeoglu, S. Celik and D. Demirel. “HLA-G in Testicular Germ Cell Tumors,” Oncol Res Treat, 2014; 37: 245–248
- Information O., B. Karagoz, O. Turken, M. Gultepe, A. Ozgun, T. Tuncel, L. Emirzeoglu, S. Celik, T. Muftuoglu and EG. Kandemir, “CD4 + CD25high, CD8 + CD28– cells and thyroid auto-antibodies in breast cancer patients,” Central Eur J Immun 2014; 39 (3): 338-344.
- Tuncel T, Ozgun A, Emirzeoglu L, Celik S, Bilgi O and Karagoz B. “Mean platelet volume as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab-combined chemotherapy.” Asian Pac J Cancer Prev. 15 (15): 6421-3 (2014)
- Adayener, C., İ. Akyol, B. Sen, F. Ates, A. Haholu, H. Soydan and B. Karagoz, “Sertoli Cell Tumor of the Testis: A Case with Late Metastasis,” Int Urol Nephrol, 40 (4), 1005-1008 (2008).
- Karagöz, B., O. Information, İ. Akyol, A. Ozgun, O. Turken and EG Kandemir, “Cerebrovascular Accident after Chemotherapy for Testicular Cancer,” Mil Med, 174 (3), 320-321 (2009).
- Karagoz, B., A. Ayata, O. Bilgi, G. Uzun, M. Unal, EG Kandemir, A. Ozgun, O. Turken, “Hemi central Retinal Artery Occlusion in a Breast Cancer Patient Using Anastrazole,” Onkologie, 32 (7), 421-423 (2009)
- Turken, O., C. Basekim, A. Haholu, B. Karagoz, O. Bilgi, A. Ozgun, Y. Kucukardali, Y. Narin, Y. Yazgan and EG Kandemir, “Hyper-ammonemic Encephalopathy in a Patient with Primary Hepatic Neuro-endocrine Carcinoma, ”Med Oncol. 26 (3), 309-313 (2009)
- Erikci, AA, Ö. Sayan, B. Karagöz, Z. Büyükodacı, and M. Velioğlu, “Intracerebral Plasma-cytoma as an Initial Presentation of Multiple Myeloma”, Central European Journal of Medicine, DOI: 10.2478 / s11536-009-0104-8 [Electronic Edition] (2009) ).
- Karagöz, B., O. Bilgi, A. Özgün, A. Alacacıoğlu, B. Yılmaz and EG Kandemir, “Autoimmunity and Thyroid Dysfunction during Sunitinib Treatment in Metastatic Renal Cell Carcinoma”, Endocrinologist, 19 (5), 224-225 (2009)
- Information, O., B. Karagöz, H. Çermik, O. Türken and EG Kandemir, "A Case of Neck Metastasis in Early Stage of Gastric Carcinoma", UHOD, 20 (2), 119-121 (2010)
- Filiz, A. İ., İ. Sücüllü, Y. Kurt, O. School, Z. Küçük Küçükdadacı, and B. Karagöz, “Seminoma presented with acute abdomen due to ileum perforation”, Centre l European Journal of Medicine, DOI: 10.2478 / s11536-009-0128-0 (2009) ).
- Caliskan T, A. Ozgun, E. Demirer, A. Haholu, B. Karagoz and Farmer F. Aggressive and HIV-negative HHV8-unrelated Primary Effusion-like Lymphoma with T-cell phenotype: A Rare Case Report. Acta Medica Mediterranean, 30, 127-130 (2014)
- Ozgun A, Tuncel T, Emirzeoglu L, Celik S, Bilgi O, Haholu A, Urhan M, Karagoz B. Malignant melanoma and papillary thyroid carcinoma that were diagnosed concurrently and were treated simultaneously: A rare case report and review of the literature. Oncology Letters 2014
- Tuncel T, Ozgun A, Emirzeoglu L, Celik S, Bilgi O, Karagoz B. Broca's Aphasia: Case report and review of the literature. Oncology Letters, 2014
- Akyol AE, Karagöz B, Bilgi O. Regulatory T cells in patients with Idiopathic Thrombocytopenic Purpura. Turk J Hematol 2016; 33: 153-155
- Turken, O., B. Karagöz, O. Bilgi, B. Doğan, EG Kandemir and E. Kunter, “Oral Etoposide-Induced Leucocytoclastic Vasculitis in a Patient with Lung Carcinoma,” J Eur Acad Dermatol Venereol, 21 (9), 1297-1298 (2007).
- Atasoyu, EM, O. Bigi, RC Kinalp, B. Karagoz, A. Haholu, S. Unver and TR Evrenkaya, “Cutaneous Kaposi's Sarcoma Fallowing Immunosuppressive Therapy for Membranoproliferative Glomerulonephritis”, Clinical Nephrology, 72 (5), 420-421 ( 2009).
- Information, O., B. Karagöz, A. Alacacıoğlu, A. Özgün, T. Tuncel and EG Kandemir, “Irinotecan and cisplatin vs. cyclophosphamide, doxorubicin, and vincristine as second line treatment after platinum and Etoposide in small cell lung cancer”, J BUON, 15 (2), 395 (2010).
- Ozgun A, Tuncel T, Emirzeoglu L, Bilgi O, Karagoz B. Epidemiological characteristics of patients who died of cancer in Haydarpaşa Training Hospital, Istanbul. Croatian Medical Journal 2012; 53 (6): 645.
- Karagoz B. and Bilgi O, Systemic Treatment in Ductal Carcinoma in situ, The Journal of Breast Health 2013; 9: 44-7.
- Erikci, AA, A. Ozturk, Ö. Sayan, O. Bilgi and B. Karagoz, “Acute lymphoblastic leukemia presented with priapism”, Balkan Military Medical Review, 11, 146-147 (2008)
- Information O, Karagoz B, Alacacioglu A, Tuncel T, Ozgun A, Emirzeoglu L, Kandemir EG. The effect of Cisplatin-Etoposide Chemotherapy on platelet parameters in lung cancer patients Disease and Molecular Medicine 2013; 1 (2): 35-38.
- Karagoz B. and O. Information, Individualized Systemic Treatment of Lung Cancer. Disease and Molecular Medicine 2013; 1 (1): 15-18.
- Karagöz B, Bilgi O, Özgün A, Emirzeoğlu L, Çelik S and Abstract A. '' Long term survival with the combination of interferon and chemotherapy in metastatic melanoma '' J Egypt Natl Canc Inst. 27 (3): 2015: 61-3.
- Karagöz B, Özgün A, Emirzeoğlu L, Tuncel T, Çelik S, Bilgi O and Kara K. “Long-term survival after Lapatinib Rechallenge in Isolated Brain Metastasis of HER2-positive Breast Cancer” J Breast Health 2015; 11: 48-51.
Send Your Enquiry
Fill in your details and our medical experts will contact you within 24 hours.
Want to consult the doctor?
Don't Ignore Your Health!
Other Top Medical Oncologist In Istanbul
Chat
Dr. Mustafa Ozdogan
Medical Oncologist
Memorial Hospitals Group, İstanbul · Istanbul
16+ years of experience
Assoc. Dr. Fatih Selcukbiricik
5.0 (12 Ratings)
Medical Oncologist
KOC University Hospital, Istanbul · Istanbul
19+ years of experience
Dr. Mustafa Yaylaci
Medical Oncologist
Kolan International Hospital, Istanbul · Istanbul
17+ years of experience
FAQ's About Dr. Bulent Karagoz
Where does Dr. Bulent Karagoz practice?
Dr. Bulent Karagoz practices at Anadolu Medical Center, Kocaeli, Istanbul
What is the specialty of Dr. Bulent Karagoz?
Dr. Bulent Karagoz specialty is Medical Oncologist
What is the experience of Dr. Bulent Karagoz?
Dr. Bulent Karagoz is Medical Oncologist with 25 years of experience.
Chat